Journal List > J Nutr Health > v.48(2) > 1081380

Bae, Yun-Jung, and Mi-Ja: Effects of coffee powder supplementation on the blood glucose and antioxidative enzyme activity of liver tissue in STZ-induced diabetic rats

Abstract

Purpose:

The purpose of this study was to evaluate the role of coffee in diabetic rats in order to prevent hyperglycemia and hyperlipidemia, and to improve antioxidant enzyme activity in streptozotocin induced diabetic rats.

Methods:

Thirty two male Sprague-Dawley rats (body weight 200 ± 5 g) were divided into two groups; diabetic and nondiabetic groups. The groups were each randomly divided into two subgroups; fed control and coffee (5 g coffee powder/kg diet) diets. Diabetes was induced by intramuscular injection of 50 mg streptozotocin/kg body weight. Rats with blood glucose concentrations ≥ 300 mg/dL were considered diabetic for these experiments. All rats were fed an experimental diet and deionized water ad libitum for 4 weeks.

Results:

The results of this study indicate that body weight gain was significantly lower in diabetic groups than in nondiabetic groups regardless of diet. Mean food intake was significantly higher in diabetic groups than in nondiabetic groups, and significantly higher in the coffee group than in the control group in diabetic rats. Food efficiency ratio (FER) was significantly lower in diabetic groups than in nondiabetic groups regardless of diet. The fasting blood glucose of coffee supplemented groups was significantly lower compared with the control group in diabetic and nondiabetic rats. The levels of serum LDL-cholesterol and atherogenic index were significantly lower in the coffee group than in the control group in diabetic and nondiabetic rats, and serum HDL-cholesterol was significantly higher in the coffee group than in control groups. The contents of hepatic triglyceride were significantly lower in the coffee group than in the control group in diabetic and nondiabetic rats. The lipid peroxidation of malondialdehyde (MDA) contents was significantly lower in the coffee group than in the control group in diabetic and nondiabetic rats. Activity of superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase in liver was not significantly different by experimental diets among all groups.

Conclusion:

In conclusion, effects of 0.5% coffee powder supplemented diet were beneficial on blood glucose and lipids in diabetic rats.

REFERENCES

1.Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2013: Korea National Health and Nutrition Examination Survey (KNHANES VI-1). Cheongju: Korea Centers for Disease Control and Prevention;2014.
2.Akash MS., Rehman K., Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013. 114(3):525–531.
crossref
3.Wolff SP., Jiang ZY., Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med. 1991. 10(5):339–352.
crossref
4.Borrelli RC., Visconti A., Mennella C., Anese M., Fogliano V. Chemical characterization and antioxidant properties of coffee melanoi-dins. J Agric Food Chem. 2002. 50(22):6527–6533.
crossref
5.Farah A., Donangelo CM. Phenolic compounds in coffee. Braz J Plant Physiol. 2006. 18(1):23–36.
crossref
6.van Dam RM., Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002. 360(9344):1477–1478.
crossref
7.van Dam RM., Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005. 294(1):97–104.
8.Cai L., Ma D., Zhang Y., Liu Z., Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012. 66(8):872–877.
crossref
9.Driessen MT., Koppes LL., Veldhuis L., Samoocha D., Twisk JW. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr. 2009. 63(4):536–542.
crossref
10.van Dam RM., Dekker JM., Nijpels G., Stehouwer CD., Bouter LM., Heine RJ. Hoorn study. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia. 2004. 47(12):2152–2159.
crossref
11.Kang KJ., Choi SS., Han HK., Kim KJ., Kwon SY. Effects of instant coffee on weight, plasma lipids, leptine and fat cell size in rats fed on a high fat diet. Korean J Food Sci Technol. 2004. 36(3):478–483.
12.Reeves PG., Nielsen FH., Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993. 123(11):1939–1951.
crossref
13.Friedewald WT., Levy RI., Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972. 18(6):499–502.
crossref
14.Folch J., Lees M., Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957. 226(1):497–509.
crossref
15.Aebi H. Catalase. Bergmeyer HU, Gawehn K, editors. editors.Methods of Enzymatic Analysis. 2nd edition.New York (NY): Academic Press;1974. p. 673–684.
crossref
16.Paglia DE., Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967. 70(1):158–169.
17.Martin JP Jr., Dailey M., Sugarman E. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys. 1987. 255(2):329–336.
crossref
18.Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979. 95(2):351–358.
crossref
19.Akash MS., Rehman K., Chen S. An overview of valuable scientific models for diabetes mellitus. Curr Diabetes Rev. 2013. 9(4):286–293.
crossref
20.Greenberg JA., Boozer CN., Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr. 2006. 84(4):682–693.
crossref
21.Muroyama K., Murosaki S., Yamamoto Y., Odaka H., Chung HC., Miyoshi M. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice. J Nutr Sci Vitaminol (Tokyo). 2003. 49(1):56–63.
crossref
22.Abreu RV., Silva-Oliveira EM., Moraes MF., Pereira GS., Moraes-Santos T. Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains. Pharmacol Biochem Behav. 2011. 99(4):659–664.
crossref
23.Salazar-Martinez E., Willett WC., Ascherio A., Manson JE., Leitz-mann MF., Stampfer MJ., Hu FB. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004. 140(1):1–8.
crossref
24.Loopstra-Masters RC., Liese AD., Haffner SM., Wagenknecht LE., Hanley AJ. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia. 2011. 54(2):320–328.
crossref
25.Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008. 22(3):659–661.
26.Onuegbu AJ., Agbedana EO. The effects of coffee consumption on serum lipids and lipoprotein in healthy individuals. Afr J Med Med Sci. 2001. 30(1-2):43–45.
27.Sakamoto W., Isomura H., Fujie K., Takahashi K., Nakao K., Izumi H. Relationship of coffee consumption with risk factors of atherosclerosis in rats. Ann Nutr Metab. 2005. 49(3):149–154.
crossref
28.Cornelis MC., El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Clin Nutr Metab Care. 2007. 10(6):745–751.
crossref
29.Ministry of Food and Drug Safety (KR). [Internet]. Cheongju: Ministry of Food and Drug Safety;2008. [cited 2015 Feb 2]. Available from:. http://www.mfds.go.kr.
30.Lovallo WR., Wilson MF., Vincent AS., Sung BH., McKey BS., Whitsett TL. Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension. 2004. 43(4):760–765.
crossref
31.Sung JH., Chang CC., Chang YS. The effect of caffeine on the antioxidative activities of mouse liver. Korean J Food Nutr. 2004. 17(4):442–449.
32.Rossowska MJ., Ghanaei P., Nakamoto T. Effect of dietary caffeine and zinc on the activity of antioxidant enzymes, zinc, and copper concentration of the heart and liver in fast-growing rats. Biol Trace Elem Res. 1995. 50(3):229–236.
crossref
33.Kim HY., Chung HS. Effect of dietary iron and coffee intake on oxidative stress and antioxidative enzyme activities of rats. Korean J Nutr. 2002. 35(9):919–925.
34.Vicente SJ., Ishimoto EY., Cruz RJ., Pereira CD., Torres EA. Increase of the activity of phase II antioxidant enzymes in rats after a single dose of coffee. J Agric Food Chem. 2011. 59(20):10887–10892.
35.Ko YH., Kang SY., Jang IS. Effects of dietary supplementation of coffee meal on growth performance, blood biochemical profiles and antioxidant defense system in broiler chickens. Korea J Poult Sci. 2012. 39(3):223–232.
crossref
36.Yukawa GS., Mune M., Otani H., Tone Y., Liang XM., Iwahashi H., Sakamoto W. Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry (Mosc). 2004. 69(1):70–74.
crossref
37.Natella F., Nardini M., Belelli F., Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr. 2007. 86(3):604–609.
crossref

Table 1.
Composition of experimental diets (g/kg diet)
Ingredient Dietary group
Control Coffee
Corn starch 529.5 524.5
Sucrose 100 100
Casein1) 200 200
Soybean oil 70 70
Cellulose2) 50 50
Mineral-mix3) 35 35
Vitamin-mix4) 10 10
L-Cystine5) 3.0 3.0
Choline bitartrate6) 2.5 2.5
TBHQ7) 0.014 0.014
Coffee8) - 5.0

1) Casein, Maeil Dairy industry Co. Ltd. Pyungtaek- City, Kyunggi-Do, Korea

2) α-Cellulose, supplied by SIGMA Chemical company

3) AIN-93G-MX, Teklad Test Diets, Medison, Wisconsin, USA

4) AIN-93-VM, Teklad Test Diets, Medison, Wisconsin, USA

5) L-Cystine, Sigma Chemical Co., St. Louis, MO, USA

6) Choline bitartrate, Sigma Chemical Co., St. Louis, MO, USA

7) Tert-bultyl Hydroquione, Sigma-Aldrich Inc., St. Louis, MO, USA

8) Maxim well-being polyphenol coffee, Dongsuh, Co., Ma-fo, Seoul, Korea

Table 2.
The effect of coffee powder on body weight gain in diabetic rats
Group Non-Diabetic rats Diabetic rats
Control Coffee Control Coffee
Initial weight (g) 215.7 ± 4.81) 215.2 ± 3.5 208.2 ± 17.0 215.2 ± 14.0
Final weight (g) 381.8 ± 19.7a2) 387.1 ± 25.8a 215.2 ± 37.7c 247.8 ± 13.1b
Weight gain (g) 166.1 ± 21.2a 171.9 ± 27.2a 7.0 ± 25.3b 32.5 ± 13.7b

1) Mean ± SD

2) Values with different superscripts within the row are significantly different at p < 0.05 by Duncan's multiple range test

Table 3.
The effect of coffee powder on food intake and food efficiency ratio (FER) in diabetic rats
Group Non-Diabetic rats Diabetic rats
Control Coffee Control Coffee
Mean food intake (g/day) 22.5 ± 2.21)c2) 22.9 ± 2.7c 29.6 ± 6.2b 35.8 ± 5.1a
FER 0.3370 ± 0.0528a 0.3396 ± 0.0219a 0.0036 ± 0.0468b 0.0444 ± 0.0201b

1) Mean ± SD

2) Values with different superscripts within the row are significantly different at p < 0.05 by Duncan's multiple range test

Table 4.
The effect of coffee powder on fasting glucose and serum lipid concentrations in diabetic rats
Group Non-Diabetic rats Diabetic rats
Control Coffee Control Coffee
Blood Glucose (mg/dL) 116.5 ± 31.41)c2) 105.0 ± 29.7d 366.0 ± 55.2a 295.4 ± 49.7b
Total cholesterol (mg/dL) 114.8 ± 11.3 104.8 ± 13.1 115.9 ± 9.9 110.3 ± 8.2
Triglyceride (mg/dL) 71.1 ± 8.2 64.1 ± 16.5 73.9 ± 11.3 69.8 ± 13.0
HDL - cholesterol (mg/dL) 17.8 ± 2.8b 19.5 ± 2.5a 14.7 ± 4.6c 17.9 ± 3.2b
LDL - cholesterol (mg/dL) 111.2 ± 10.9b 98.0 ± 15.3c 116.0 ± 9.8a 106.3 ± 10.2b
Atherogenic index 5.5 ± 0.9b 4.4 ± 1.2c 7.6 ± 2.8a 5.4 ± 1.7b

1) Mean ± SD

2) Values with different superscripts within the row are significantly different at p < 0.05 by Duncan's multiple range test.

Table 5.
The effect of coffee powder on the liver lipid and malondialdehyde content in diabetic rats
Group Non-Diabetic rats Diabetic rats
Control Coffee Control Coffee
Triglyceride (mg/g) 35.1 ± 2.01)a2) 30.4 ± 0.8b 24.6 ± 1.3c 21.7 ± 1.4d
Total cholesterol (mg/g) 40.8 ± 2.5b 39.0 ± 1.8b 44.8 ± 1.8a 43.6 ± 0.4a
Malondialdehyde (nmoleMDA/g) 3.26 ± 0.4a 2.87 ± 0.17b 3.15 ± 0.18ab 3.04 ± 0.05ab

1) Mean ± SD

2) Values with different superscripts within the row are significantly different at p < 0.05 by Duncan's multiple range test.

Table 6.
The effect of coffee powder on the liver activities of SOD, GPx, catalase in diabetic rats
Group Non-Diabetic rats Diabetic rats
Control Coffee Control Coffee
SOD (unit/mg protein/min) 4.62 ± 6.871) 5.53 ± 5.19 4.72 ± 2.58 5.03 ± 2.10
GPx (nmol NADPH/mg protein/min) 14.32 ± 5.05 17.38 ± 6.61 13.77 ± 6.07 18.82 ± 1.90
Catalase (nmole H2O2 reduced/mg protein/min) 50.94 ± 17.09ab 63.19 ± 13.09a 35.31 ± 17.54b 43.50 ± 2.24b

1) Mean ± SD

2) Values with different superscripts within the row are significantly different at p < 0.05 by Duncan's multiple range test.

TOOLS
Similar articles